Cryptococcal Optimal ART Timing Trial

NCT01075152 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

177

Enrollment

OTHER

Sponsor class

Conditions

Cryptococcal Meningitis
HIV Infections
AIDS

Interventions

DRUG: efavirenz
BIOLOGICAL: nucleoside

Sponsor

University of Minnesota

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]